Stay updated on Extension Study of BMN 111 in Achondroplasia Children Clinical Trial
Sign up to get notified when there's something new on the Extension Study of BMN 111 in Achondroplasia Children Clinical Trial page.

Latest updates to the Extension Study of BMN 111 in Achondroplasia Children Clinical Trial page
- Check3 days agoChange DetectedThe page shows a new revision: v3.3.4 replaces v3.3.3, with no visible changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a comprehensive Locations section listing study sites in California, Delaware, Georgia, Illinois, Maryland, Missouri, Ohio, Texas, Washington, Wisconsin, New South Wales, and Victoria. Updated footer links and versioning (removal of HHS Vulnerability Disclosure and change from v3.3.2 to v3.3.3).SummaryDifference1%

- Check54 days agoChange DetectedThe Study Details page now indicates PubMed publications are automatically filled from PubMed and may not be about the study, and the revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page no longer displays the government funding status notice related to operating status and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check75 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.4%

- Check104 days agoChange DetectedMajor update: page now includes a government funding status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference4%

Stay in the know with updates to Extension Study of BMN 111 in Achondroplasia Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of BMN 111 in Achondroplasia Children Clinical Trial page.